DISCOVER
our Quality& credentials
Quality Management
at the very centre
of the Telemedicine Technologies corporate
strategy
ISO 9001:2015 certification
ISO 27001 HDS
21 CRF part 11 FDA
and with ICH E6-E9, ICH Q9-Q10, European Directives 2001/20/EC / Directive 2005/28/EC, Annex 11, cGMP
CDISC-ODM Certification
Information System Validation:
GAMP-5 methodology
National Qualiopi certification,
a new quality guarantee for
training providers in France
Some key figures that testify to our involvement and leadership in
the clinical research industry for over 20 years
64 +
countries
involved
20 000 +
investigational
center
2 million +
patients
in database
50 000 +
users
worlwide
97%
overall trainee
satisfaction rate
90+
monitored
servers
5 500+
projects
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
November 30, 2023
📅 5th December – 1:30pm to 2:15pm (CET) 📍 On line via Gotowebinar 💶 Free but mandatory registration Register In Clinical Research, difficulties in recruiting subjects are one of the main causes of premature termination of clinical trials. Between 20 to 30% of clinical trials are affected by inclusion delays and more than 1 out of […]
November 30, 2023
Applied Clinical Trials Online Site and project management teams play major roles in risk-management and monitoring performance. As the modernization of clinical research through digital and decentralized solutions continues to take research into local communities, reduce patient and site burden, and increase diversity, it will lead to new ways of working for project delivery teams. […]
November 30, 2023
Applied Clinical Trials Online Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are. In a study published earlier this month by JAMA, the authors aimed to discover how the pharmaceutical industry gets involved in the most influential modern clinical trials and how they fare […]